MINNEAPOLIS--(BUSINESS WIRE)--MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today announced that it has filed amended Form 10-Qs for the second and third quarters of 2006. The amended quarterly filings correct certain line items in the Condensed Consolidated Statements of Cash Flows. Importantly, the Company’s Condensed Consolidated Statements of Operations and Condensed Consolidated Balance Sheets remain as originally filed, and there is no net impact to the Company’s total cash and cash equivalents.
